232 related articles for article (PubMed ID: 33468155)
1. Identification of potential CpG sites for oral squamous cell carcinoma diagnosis via integrated analysis of DNA methylation and gene expression.
Chen L; Wang D
World J Surg Oncol; 2021 Jan; 19(1):16. PubMed ID: 33468155
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
3. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
5. A two-CpG-based prognostic signature for oral squamous cell carcinoma overall survival.
Chen Y; Hei N; Zhao J; Peng S; Yang K; Chen H; Cui Z; Jin L; Sun R; Guo J
J Cell Biochem; 2019 Jun; 120(6):9082-9090. PubMed ID: 30548666
[TBL] [Abstract][Full Text] [Related]
6. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
7. Sixteen Cellular Senescence-associated DNA Methylation Signature Predicts Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Ye MH; Huang XY; Li CJ; Wu QJ; Liu F
Chin J Dent Res; 2023 Dec; 26(4):235-248. PubMed ID: 38126369
[TBL] [Abstract][Full Text] [Related]
8. CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel.
Morandi L; Gissi D; Tarsitano A; Asioli S; Gabusi A; Marchetti C; Montebugnoli L; Foschini MP
Clin Epigenetics; 2017; 9():85. PubMed ID: 28814981
[TBL] [Abstract][Full Text] [Related]
9. Pre-Operative Evaluation of DNA Methylation Profile in Oral Squamous Cell Carcinoma Can Predict Tumor Aggressive Potential.
Gissi DB; Fabbri VP; Gabusi A; Lenzi J; Morandi L; Melotti S; Asioli S; Tarsitano A; Balbi T; Marchetti C; Montebugnoli L
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937734
[TBL] [Abstract][Full Text] [Related]
10. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
[TBL] [Abstract][Full Text] [Related]
11. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
[No Abstract] [Full Text] [Related]
12. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
Zhu Q; Tian G; Gao J
Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
[TBL] [Abstract][Full Text] [Related]
14. Promoter Methylation of Cancer Stem Cell Surface Markers as an Epigenetic Biomarker for Prognosis of Oral Squamous Cell Carcinoma.
Han YK; Park HY; Park SG; Hwang JJ; Park HR; Yi JM
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498950
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic landscape of oral squamous cell carcinoma.
Jithesh PV; Risk JM; Schache AG; Dhanda J; Lane B; Liloglou T; Shaw RJ
Br J Cancer; 2013 Feb; 108(2):370-9. PubMed ID: 23287992
[TBL] [Abstract][Full Text] [Related]
16. Identification of hub methylated-CpG sites and associated genes in oral squamous cell carcinoma.
Dai Y; Lv Q; Qi T; Qu J; Ni H; Liao Y; Liu P; Qu Q
Cancer Med; 2020 May; 9(9):3174-3187. PubMed ID: 32155325
[TBL] [Abstract][Full Text] [Related]
17. [Comparative analysis of methylation profiles in tissues of oral leukoplakia and oral squamous cell carcinoma].
Fu J; Su Y; Liu Y; Zhang XY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):248-253. PubMed ID: 29690695
[No Abstract] [Full Text] [Related]
18. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
Inchanalkar M; Srivatsa S; Ambatipudi S; Bhosale PG; Patil A; Schäffer AA; Beerenwinkel N; Mahimkar MB
Clin Epigenetics; 2023 May; 15(1):93. PubMed ID: 37245006
[TBL] [Abstract][Full Text] [Related]
19. CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology.
Shaw RJ; Hall GL; Lowe D; Bowers NL; Liloglou T; Field JK; Woolgar JA; Risk JM
Oral Oncol; 2007 Oct; 43(9):878-86. PubMed ID: 17257884
[TBL] [Abstract][Full Text] [Related]
20. Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype.
Brennan K; Koenig JL; Gentles AJ; Sunwoo JB; Gevaert O
EBioMedicine; 2017 Mar; 17():223-236. PubMed ID: 28314692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
